New Study: This Broccoli Compound Could Reduce Your Risk of Type 2 Diabetes

From scitechdaily.com

A study found that sulforaphane, a compound in broccoli sprouts, significantly lowered fasting blood sugar levels in people with prediabetes.

Researchers at the University of Gothenburg previously identified sulforaphane as a potential antidiabetic compound for type 2 diabetes. A 2017 clinical study showed that participants with diabetes experienced significantly lower blood sugar levels after taking high doses of sulforaphane extracted from broccoli sprouts.

In their latest study, published in Nature Microbiology, Professor Anders Rosengren and his team focused on prediabetes—a condition that precedes type 2 diabetes and is characterized by gradually increasing blood sugar levels due to impaired insulin production.

The study encompassed 89 people with elevated fasting blood sugar, an indicator of prediabetes. Other criteria included the participants being overweight or obese and 35–75 years old.

The participants were randomly assigned sulforaphane or a placebo for twelve weeks. Neither the participants nor the researchers knew who was assigned which. A total of 74 participants completed all stages of the study.

Broccoli sprouts contain sulforaphane, which significantly improved fasting blood sugar levels in people with prediabetes, especially in those with early signs of age-related diabetes and favourable gut bacteria. A University of Gothenburg study found that participants taking sulforaphane experienced larger blood sugar reductions than those on a placebo

Fasting blood sugar fell

The results show that participants taking the sulforaphane compound had a higher average reduction in fasting blood sugar than those taking the placebo. The difference between the two groups in the study was considerable.

An even greater difference was seen when analysing clinical subgroups. The group with the greatest improvement after taking sulforaphane had early signs of mild age-related diabetes, a relatively low BMI in the context of the study, low insulin resistance, low incidence of fatty liver disease, and low insulin secretion.

The third stage, conducted in collaboration with Professor Fredrik Bäckhed at the University of Gothenburg, involved the study of gut bacteria, with the discovery of a gut bacterium able to interact with sulforaphane that could be linked to further improved efficacy of the broccoli compound.

In terms of numbers, the differences in fasting blood sugar were 0.2 millimoles per liter between all participants taking sulforaphane compared to the placebo group, followed by 0.4 in the concerned clinical subgroup, and 0.7 in those who were both in the clinical subgroup and had the gut bacterium.

Possible precision treatment

The prevalence of prediabetes in Sweden is estimated to be up to ten percent, with no clear treatment structure currently in place. While the condition often remains undetected, early detection increases the chances of not developing type 2 diabetes. Anders Rosengren emphasizes the importance of early and individualized interventions to prevent the disease.

“The treatment of prediabetes is currently lacking in many respects, but these new findings open the way for possible precision treatment using sulforaphane extracted from broccoli as a functional food. However, lifestyle factors remain the foundation of any treatment for prediabetes, including exercise, healthy eating, and weight loss,” he says.” The results of the study also offer a general model of how pathophysiology and gut flora interact with and influence treatment responses. A model that could have broader implications,” Anders Rosengren ends.

https://scitechdaily.com/new-study-this-broccoli-compound-could-reduce-your-risk-of-type-2-diabetes/